{"id":2833,"date":"2016-04-22T13:16:00","date_gmt":"2016-04-22T11:16:00","guid":{"rendered":"http:\/\/oncomatryx.com\/?p=2833"},"modified":"2016-04-22T13:16:00","modified_gmt":"2016-04-22T11:16:00","slug":"presentacion-aspic-poster","status":"publish","type":"post","link":"https:\/\/oncomatryx.com\/es\/presentacion-aspic-poster\/","title":{"rendered":"Nueva publicaci\u00f3n presentada en el ASPIC"},"content":{"rendered":"<p><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone wp-image-2819 size-full\" src=\"http:\/\/oncomatryx.com\/wp-content\/uploads\/2015\/07\/banner_2nd_congress_1.jpg\" alt=\"Aspic oncomatryx\" width=\"760\" height=\"250\" \/><\/p>\n<h2><span style=\"color: #99ccff;\"><strong>Presentaci\u00f3n en el 2\u00ba Congreso Internacional\u00a0ASPIC. 28-29 Abril, 2016<strong>. Oporto. Portugal.<\/strong><\/strong><\/span><\/h2>\n<h2>Nos complace comunicar que el equipo de Enrique De \u00c1lava del\u00a0Hospital Virgen del Roc\u00edo de Sevilla presentar\u00e1 en el\u00a0ASPIC el poster<span class=\"il\"> \u201cT<\/span>argeting Ewing Sarcoma Cells and the tumor microenvironment\u00a0with OMTX003 Anti-Endoglin Monoclonal Antibodies\u201d que cuenta con\u00a0los resultados obtenidos con el trabajo de investigaci\u00f3n desarrollado en colaboraci\u00f3n de Oncomatryx.<\/h2>\n","protected":false},"excerpt":{"rendered":"<p>Presentaci\u00f3n en el 2\u00ba Congreso Internacional\u00a0ASPIC. 28-29 Abril, 2016. Oporto. Portugal. Nos complace comunicar que el equipo de Enrique De \u00c1lava del\u00a0Hospital Virgen del Roc\u00edo de Sevilla presentar\u00e1 en el\u00a0ASPIC el poster \u201cTargeting Ewing Sarcoma Cells and the tumor microenvironment\u00a0with OMTX003 Anti-Endoglin Monoclonal Antibodies\u201d que cuenta con\u00a0los resultados obtenidos con el trabajo de investigaci\u00f3n desarrollado &#8230; <a title=\"Nueva publicaci\u00f3n presentada en el ASPIC\" class=\"read-more\" href=\"https:\/\/oncomatryx.com\/es\/presentacion-aspic-poster\/\" aria-label=\"Leer m\u00e1s sobre Nueva publicaci\u00f3n presentada en el ASPIC\">Leer m\u00e1s<\/a><\/p>\n","protected":false},"author":3,"featured_media":2835,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[22],"tags":[],"class_list":["post-2833","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias"],"_links":{"self":[{"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/posts\/2833","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/comments?post=2833"}],"version-history":[{"count":0,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/posts\/2833\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/media?parent=2833"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/categories?post=2833"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/oncomatryx.com\/es\/wp-json\/wp\/v2\/tags?post=2833"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}